fruquintinib
hutchmed
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'fresco-2', 'congrat']
fresco-2 another positive trial for mcrc in os a and pfs, heavily pretreated patients, &gt;92% had a duration of metastatic disease &gt;18m. practice changing #cancer congratulations to all the authors, 
GI medical oncologist & dogs lovers #INCan, #cancer, #esmo, #asco #aacr, oncóloga de canceres gastrointestinales y amante de perros ??